Adicon

What Adicon does

Adicon (艾迪康医学检验中心) is one of China's largest independent medical laboratory (ICL) networks, founded in January 2004 in Hangzhou as Zhejiang Province's first independent medical laboratory. The company operates 30+ medical laboratories across all major regions of China, offering 4,000+ testing items to 19,000+ cooperative customers including hospitals, clinics, pharmaceutical companies, and individual consumers. Its service portfolio spans clinical laboratory testing, pathology (with the integrated MICM diagnostic model for hematologic malignancies), reproductive genetics, molecular genetics and NGS-based oncology testing, mass spectrometry (LC-MS/MS, GC-MS, ICP-MS), and chronic disease testing, supported by proprietary technology platforms including Illumina NextSeq CN500 sequencers, Roche/Abbott/Siemens automated lines, and digital PCR systems.

The company generates revenue across three primary streams: (1) B2B institutional testing services to hospitals and medical institutions via direct field sales and laboratory co-building partnerships, priced through customized multi-year contracts based on volume and test type; (2) CRO central laboratory services for domestic and international pharmaceutical companies conducting drug clinical trials, leveraging CAP and ISO 15189 accredited facilities; and (3) direct-to-consumer testing through WeChat mini-programs (艾易检工作台, 艾易检医生端, 艾易检受检端), official mall, and home sample collection. Sample logistics are handled by Adicon's proprietary cold chain platform (艾物流) covering 1,789 counties in 30 provinces with a 12-hour delivery SLA.

Adicon operates under the holding entity 艾迪康控股有限公司 (Adicon Holdings Limited) and includes wholly-owned subsidiaries such as Crownbio (冠科生物), a US-headquartered global preclinical CRO, and 元德友勤. The group has been pursuing an "ICL+CRO dual-drive" strategic positioning since 2025, formalized through partnerships with Gan Li Pharmaceutical (June 2025), Haier Biological (July 2025), Shendi Digital (May 2025), and Crownbio (December 2025), alongside the April 2026 launch of the AI-powered ADICON Research Suite desktop application and the announcement of a Northern Production base in May 2025.

Name

Adicon

Legal name

杭州艾迪康医学检验中心有限公司 (Hangzhou Adicon Medical Laboratory Center Co., Ltd.)

Website

https://adicon.com.cn

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Adicon is a leading Chinese independent medical laboratory network operating 30+ labs offering 4,000+ diagnostic tests to 19,000+ hospitals, pharmaceutical companies, and consumers, with proprietary cold chain logistics and CAP-accredited CRO services.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Independent clinical laboratory
• Medical diagnostic testing
• Clinical research services
• Pathology laboratory services
• Cold chain logistics

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices35 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Testing Services: B2B laboratory testing services for hospitals and medical institutions, providing diagnostic testing across multiple disease areas including infection, oncology, genetics, and chronic diseases
2. Drug Clinical Research (CRO): Central laboratory testing services for pharmaceutical companies conducting drug clinical trials, including project management, sample management, and data verification
3. Individual Consumer Testing: Direct-to-consumer medical testing services through WeChat mini-programs and official mall, enabling home sample collection and report delivery

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Adicon operates an Independent Clinical Laboratory (ICL) network of 30+ medical laboratories across China providing 4,000+ diagnostic testing items to hospitals, medical institutions, pharmaceutical companies, and individual consumers. The company offers specialized clinical testing, pathology diagnostics, drug clinical research (CRO) services for pharmaceutical companies, and direct-to-consumer medical testing through WeChat mini-programs and an official service mall.

Product overview

Adicon operates as a multi-site Independent Clinical Laboratory (ICL) network offering a unified platform-plus-modules product portfolio. The core platform is its medical testing services network of 30+连锁医学实验室 providing 4,000+ diagnostic testing items. Key product modules include: (1) ADICON Research Suite — AI research desktop client for data analysis; (2) Drug Clinical/CRO Service — one-stop center laboratory for pharmaceutical clinical trials; (3) 艾物流 — proprietary cold chain logistics platform; (4) 艾易检 mini-program suite — B2C/B2B mobile testing platforms; (5) Gene/Mass Spec/Pathology/Clinical laboratories — specialized testing service lines; (6) Disease-specific solution bundles covering infectious diseases, tumors, blood diseases, chronic diseases, women's health, perinatal/pediatric care; (7) Laboratory co-building services for hospital partnerships; and (8) Crownbio — strategic CRO sub-brand. These modules are interconnected: laboratory testing services are delivered through the nationwide cold chain logistics network, CRO services enable dual ICL+CRO driving strategy, AI research client supports advanced data analysis, and co-building services extend the network reach.

Differentiator

Problem solved

Functional benefit

Brands

• 艾易检工作台: Mini-program for uploading application form photos, ID card recognition, and barcode scanning
• 艾易检医生端
• 艾易检受检端
• ADICON Research Suite
• 艾小医
• 艾迪康健康服务商城

Products and services

• Medical Testing Services (医学检验服务) Core Independent Clinical Laboratory (ICL) service providing 4,000+ testing items across 30+ medical laboratories. Serves hospitals, medical institutions, and individual consumers with comprehensive diagnostic testing in infection, oncology, hematology, genetics, reproductive health, chronic disease, and pathology.
• Drug Clinical / CRO Service (药物临床) One-stop center laboratory testing service for domestic and international pharmaceutical companies, providing project management, sample management, archive management, and data verification for drug clinical trials, covering gynecology, endocrinology, solid tumors, and pharmacogenomics.
• Cold Chain Logistics (艾物流) Proprietary cold chain logistics platform with 1,182+ logistics personnel and 700+ vehicles, providing nationwide sample transportation with GPS monitoring and multi-temperature zone control (2-8°C cold storage and 15-25°C room temperature), covering 1,789 county-level regions across 30 provinces.
• Direct-to-Consumer Testing Service (个人用户健康服务) B2C medical testing platform enabling individual consumers to order tests directly via mobile app, with home sample collection and online report access, covering cancer prevention, health indicators, and chronic disease monitoring.
• Gene Laboratory (基因实验室) Genetic testing laboratory equipped with Illumina NextSeq CN500, MiseqDX, and other NGS platforms, offering services in oncology, hematology, inherited diseases, infectious diseases, reproductive genetics, and pharmacogenomics.
• Mass Spectrometry Laboratory (质谱实验室) Mass spectrometry testing laboratory providing inherited metabolic disease screening, therapeutic drug monitoring, protein/polypeptide testing, vitamin testing, and full-spectrum amino acid testing using LC-MS/MS, GC-MS, and ICP-MS platforms.
• Pathology Laboratory (病理实验室) Comprehensive pathology service network with 20+ sub-labs and 50+ expert pathologists, offering tissue pathology, cytology, molecular pathology, flow cytometry, and cytogenetics testing across 14 specialized subspecialties.
• Clinical Laboratory (临床实验室) Large-scale clinical testing laboratory with 100,000+ square meters of total area, equipped with Roche, Abbott, Siemens, and Mindray automated platforms, staffed with 1,400+ technicians, offering routine testing, immunoassay, biochemistry, microbiology, and molecular biology.
• Reproductive Genetics Laboratory (生殖遗传实验室) Reproductive genetics testing laboratory providing chromosome karyotyping, prenatal screening, and genetic testing services with ASI and Zeiss automated analysis systems. Processes over 100,000 samples annually.
• Laboratory Co-building Services (合作共建服务) Customized laboratory collaboration solutions including laboratory planning, equipment configuration, quality management system implementation, informatization, talent development, cold chain logistics, lean operations, and brand building for partner hospitals and institutions.
• ADICON Research Suite Desktop research client application enabling medical researchers to perform AI-powered data analysis, supporting Windows and macOS platforms (Intel and Apple Silicon) with downloadable installers.
• Crownbio (冠科生物) - Global CRO Service Globally integrated Contract Research Organization (CRO) headquartered in California, USA, providing drug discovery, preclinical research, and translational platforms with focus on oncology, tumor immunology, and immune-mediated diseases. Adicon's strategic sub-brand for end-to-end laboratory services.
• Infectious Disease Solutions (感染性疾病综合解决方案) Comprehensive infectious disease testing solutions covering respiratory infections (tuberculosis, fungi, atypical pathogens), sexually transmitted infections, hepatitis B, and COVID-19, utilizing nucleic acid amplification, biochip, mass spectrometry, gene sequencing, and metagenomic sequencing (mNGS) technologies.
• Solid Tumor Solutions (实体肿瘤综合解决方案) Comprehensive solid tumor testing covering lung cancer (23-gene NGS panel), colorectal cancer (22-gene NGS), thyroid cancer (65-gene panel), and breast cancer (BRCA1/2), providing early diagnosis, treatment guidance, prognosis, and recurrence monitoring across the cancer care cycle.
• Hematologic Tumor Genetic Pathology (血液肿瘤基因病理学) Blood cancer comprehensive diagnostic center led by Chief Scientist Dr. Yang Fan, implementing the MICM (Morphology, Immunology, Cytogenetics, Molecular biology) diagnostic model and offering 600+ hematologic disease testing items including acute/chronic myeloid leukemia, acute/chronic lymphoblastic leukemia, multiple myeloma, MDS, MPN, and NHL.
• 艾易检 Mini-Program Suite (艾易检工作台/医生端/受检端) WeChat mini-program suite providing testing application form upload, ID card recognition, barcode scanning, report inquiry, and clinical decision support functionality for doctors (艾易检医生端) and individual consumers (艾易检受检端).

Quantifiable outcome

• 30+ medical laboratories nationwide
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• Crownbio (冠科生物)coreStrategic or Co-development PartnerCrownbio is a global contract research organization (CRO) headquartered in California, USA. Adicon partnered with Crownbio to create a global end-to-end laboratory service platform, combining Adicon's laboratory testing capabilities with Crownbio's preclinical research services for drug discovery and development.
• Haier Biological (海尔生物)strategicTechnology or IntegrationStrategic cooperation focusing on digital operation and smart laboratory solutions, leveraging Haier's IoT technology and cold chain capabilities.
• Gannu Medicine (甘李药业)strategicStrategic or Co-development PartnerICL+CRO dual-drive strategic partnership providing comprehensive laboratory services for Gannu's drug clinical trials and diagnostics.
• Shendi Digital (神州数码)strategicTechnology or IntegrationAI-powered smart medical laboratory cooperation leveraging Shendi's AI and digital transformation capabilities to enhance Adicon's intelligent testing services.
• 100+ Strategic PartnerscoreOthersPartnerships with国内外先进检验设备 and reagent耗材 manufacturers providing comprehensive solutions for laboratory operations.

Scale indicators20 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kingmed Diagnostics: China's largest independent clinical laboratory (ICL) operator (~38+ labs nationwide) with comparable B2B hospital testing, specialty diagnostics, and CRO central-lab services. Closest direct competitor to Adicon in the Chinese ICL market, with similar customer base and test menu breadth.
• Dian Diagnostics: Major Chinese ICL and diagnostic product distributor (~40+ labs) offering both routine clinical testing and specialty diagnostics. Direct competitor to Adicon in B2B hospital testing, with a more vertically integrated channel via diagnostic product distribution.
• BGI Genomics: China-based genomics and clinical testing company with strong NGS-based oncology, reproductive health, and infectious disease testing capabilities. Comparable to Adicon's specialty genetic and genomic testing lines, though BGI's primary identity is genomics-led.

Broad incumbents

• Laboratory Corporation of America (LabCorp): Global ICL incumbent with central laboratory operations, specialty testing, and clinical trial central lab services. Comparable in business model mix (routine diagnostics + specialty + CRO central lab) though operating primarily in the US/Europe rather than China.
• Quest Diagnostics: Global ICL incumbent offering routine and advanced clinical testing plus clinical trial central lab services through its Q² Solutions joint venture. Comparable business model across diagnostic testing, specialty assays, and pharma services, with global rather than China-focused scale.
• Sonic Healthcare: Global medical diagnostics operator with ICL networks across Australia, Europe, and the US, providing routine pathology, specialty diagnostics, and clinical trial central lab services. Comparable mix to Adicon across diagnostic testing and CRO central-lab work.
• WuXi AppTec: Global CRO/CDMO with extensive preclinical and clinical laboratory capabilities in China. Comparable to Crownbio (Adicon's CRO subsidiary) for preclinical research services, and comparable to Adicon's CRO central lab offering for drug development customers.
• Charles River Laboratories: Global preclinical and clinical CRO with research model and discovery services across oncology and immunology. Closest direct comparable to Crownbio, Adicon's wholly-owned preclinical CRO subsidiary, in business model and end customers.
• Eurofins Scientific: Global testing services group with clinical diagnostics and pharma testing lines. Comparable in scale and breadth of test menu across clinical diagnostics and pharma services, though with much broader non-clinical testing exposure.

Emerging players

• Novogene: China-based genomics services provider with NGS-based clinical and research testing. Comparable to Adicon's gene laboratory and NGS cancer testing platform in technology stack and customer base, though smaller and more research-services focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance22 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adicon